PS Ratio: 7.12

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 7.12 is 99% below its estimated 5-year average of 816.32, near the low end of its estimated 5-year range (5.83–28855.65).

As of 2026-10-06T14:52:01.156Z. 99.57% below its estimated 12-month average of 1667.32.

FDMT PS Ratio Metrics

P/S vs. estimated history

At 7.12, P/S is below its estimated 6-year median — higher than 3% of readings in its estimated 6-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for 4D Molecular Therapeutics, Inc. (FDMT)?

The P/S ratio for FDMT stock is 7.12.

Is 4D Molecular Therapeutics, Inc.'s P/S ratio high or low?

The P/S ratio of 7.12 is 99% below its estimated 5-year average of 816.32, near the low end of its estimated 5-year range (5.83–28855.65).

What is the estimated TTM average P/S ratio for 4D Molecular Therapeutics, Inc. (FDMT)?

The estimated TTM average P/S ratio for FDMT stock is 1667.32.

What is the estimated 3Y average P/S ratio for 4D Molecular Therapeutics, Inc. (FDMT)?

The estimated 3Y average P/S ratio for FDMT stock is 4231.40.

What is the estimated 5Y average P/S ratio for 4D Molecular Therapeutics, Inc. (FDMT)?

The estimated 5Y average P/S ratio for FDMT stock is 816.32.

Showing the most recent 260 of 1,459 data points. The chart above shows the full history.

Related Metrics